Singapore Med J 2013; 54:40-43; http://dx.doi.org/10.11622/smedj.2013010
Relationship between leucocytosis and left ventricular ejection fraction in patients with acute myocardial infarction
Eskandarian R, Ghorbani R, Asgary Z
Correspondence: Dr Rahime Eskandarian, Irheskandarian@yahoo.com
ABSTRACT
Introduction Myocardial infarction (MI) is common and affects a significant number of people annually. Death occurs due to either arrhythmia or heart failure. As leucocytosis, especially elevated neutrophil count, is a hallmark of inflammatory reactions in patients with MI, we investigated the relationship between leucocytosis on admission and left ventricular ejection fraction (LVEF) in patients with acute MI (AMI).
Introduction Myocardial infarction (MI) is common and affects a significant number of people annually. Death occurs due to either arrhythmia or heart failure. As leucocytosis, especially elevated neutrophil count, is a hallmark of inflammatory reactions in patients with MI, we investigated the relationship between leucocytosis on admission and left ventricular ejection fraction (LVEF) in patients with acute MI (AMI).
Methods Patients with AMI were enrolled in a case-control study. Blood samples obtained in the first 24 hours after the onset of pain were analysed for cardiac enzyme levels and cell count. Echocardiography was performed on Days 3–5. Patients with LVEF < 45% were assigned to the left ventricular (LV) systolic dysfunction group (n = 69) and those with LVEF ≥ 45% were taken as controls (n = 69). All patients were matched for variables such as hypertension, diabetes mellitus, hyperlipidaemia, family history of cardiac disease, age and gender.
Results Leucocytosis was higher in patients with systolic dysfunction (47.8%) when compared with the controls (20.3%), and was significantly associated with the development of LV systolic dysfunction (p = 0.001). Similarly, neutrophilia was more common in patients with systolic dysfunction than the controls (6.6% vs. 34.8%), and was significantly associated with LV systolic dysfunction (p < 0.001). Monocytosis was higher in the controls than the systolic dysfunction group (40.6% vs. 33.3%; p = 0.378).
Conclusion Leucocytosis and neutrophilia in the acute phase of MI are important predictive factors for the development of LV systolic dysfunction. Leucocytosis can be used for risk stratification of such patients.
Keywords: acute myocardial infarction, left ventricular systolic dysfunction, leucocytosis, monocytosis, neutrophilia
Singapore Med J 2013; 54:40-43; http://dx.doi.org/10.11622/smedj.2013009
REFERENCES
1. Antman EM, Braunwald E. ST-elevation myocardial infarction: Pathology, Pathophysiology and clinical features. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed, vol 2. Philadelphia: Elsevier Saunders, 2005: 1141-63. | ||||
2. Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R; Midlands Research Practices Consortium (MidReC). Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J 2007; 28:1128-34. http://dx.doi.org/10.1093/eurheartj/ehm102 | ||||
3. Kernis SJ, Harjai KJ, Stone GW, et al. The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2003; 42:1173-7. http://dx.doi.org/10.1016/S0735-1097(03)00920-3 | ||||
4. Antman EM, Braunwald E. ST-Segment elevation myocardial infarction. In: Kasper DL, Braunwald E, Fausi AS, et al, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Professional, 2004: 1448-59. | ||||
5. Grzybowski M, Welch RD, Parsons L, et al. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. Acad Emerg Med 2004; 11:1049-60. http://dx.doi.org/10.1111/j.1553-2712.2004.tb00676.x | ||||
6. Barron HV, Harr SD, Radford MJ, Wang Y, Krumholz HM. The association between white blood cell count and acute myocardial infarction mortality in patient > or = 65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 2001; 38:1654-61. http://dx.doi.org/10.1016/S0735-1097(01)01613-8 | ||||
7. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 2000; 102:2329-34. http://dx.doi.org/10.1161/01.CIR.102.19.2329 | ||||
8. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leucocytes and the risk of ischemic diseases. JAMA 1987; 257:2318-24. http://dx.doi.org/10.1001/jama.1987.03390170074031 | ||||
9. Ghaffari S, Hakim H, Farhanghi A. Monocytosis and congestion heart failure after acute myocardial infarction (abstract). In: Proceeding of 14th congress of Iranian Heart Association in Collaboration with British Cardiac Society, 2004 Nov 23-26: 256. | ||||
10. Green SM, Vowels J, Waterman B, Rothrock SG, Kuniyoshi G. Leucocytosis: a new look at an old marker for acute myocardial infarction. Acad Emerg Med 1996; 3:1034-41. http://dx.doi.org/10.1111/j.1553-2712.1996.tb03350.x | ||||
11. Robert E. Hutchison, Katherine I. Schexneider. Leukocytic disorders. In: Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. 20th ed. Philadelphia: WB Saunders, 2001: 1435-6. | ||||
12. Li JJ. Inflammation in coronary artery diseases. Chin Med J (Engl) 2011; 124:3568-75. | ||||
13. Sabatine MS, Morrow DA, Cannon CP, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy - Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 2002; 40:1761-8. 1 http://dx.doi.org/10.1016/S0735-1097(02)02484-1 | ||||
14. Murtagh BM, Anderson HV. Inflammation and atherosclerosis in acute coronary syndromes. J Invasive Cardiol 2004; 16:377-84. | ||||
15. Jan AF, Habib S, Naseeb K, Khatri MA, Zaman KS. High total leukocyte count and heart failure after myocardial infarction. Pak Heart J 2011; 44 No. 1-2. | ||||
16. Akhtar N, Adil MM, Ahmed W, Rehman H, Shah MA. The role of leukocyte counts in patients with unstable angina pectoris or myocardial infarction; prognostic significance and correlation with plasma brain natriuretic peptide (bnp) levels. JPMA 2011; 61:51-4. | ||||
17. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease implications for risk assessment. J Am Coll Cardiol 2004; 44:1945-56. http://dx.doi.org/10.1016/j.jacc.2004.07.056 | ||||
18. Pesaro AE, Nicolau JC, Serrano CV Jr, et al. [Influence of leukocytes and glycemia on the prognosis of patients with acute myocardial infarction]. Arq Bras Cardiol 2009; 92:84-93. English, Portuguese, Spanish. http://dx.doi.org/10.1590/S0066-782X2009000200003 | ||||
19. Arruda-Olson AM, Reeder GS, Bell MR, Weston SA, Roger VL. Neutrophilia predicts death and heart failure after myocardial infarction: A community based study. Circ Cardiovasc Qual Outcomes 2009; 2:656-62. http://dx.doi.org/10.1161/CIRCOUTCOMES.108.831024 | ||||
20. Asadollahi K, Beeching NJ, Gill GV. Leukocytosis as a predictor for noninfective mortality and morbidity. QJM 2010; 103:285-92. http://dx.doi.org/10.1093/qjmed/hcp182 | ||||
21. Mueller C, Neumann FJ, Perruchoud AP, Buettner HJ. White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation. Heart 2003; 89:389-92. http://dx.doi.org/10.1136/heart.89.4.389 | ||||
22. Cannon CP, McCabe CH, Wilcox RG, Bentley JH, Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol 2001; 87:636-9. http://dx.doi.org/10.1016/S0002-9149(00)01444-2 | ||||
23. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995; 91:1872-85. http://dx.doi.org/10.1161/01.CIR.91.6.1872 | ||||
24. Coller BS. Leucocytosis and ischemic vascular disease mortality and morbidity: is it time to intervene? Arterioscler Thromb Vasc Biol 2005; http://dx.doi.org/10.1161/01.ATV.0000156877.94472.a5 | ||||
25. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 2000; 102:2329-34. http://dx.doi.org/10.1161/01.CIR.102.19.2329 | ||||
26. Bodí V, Sanchis J, Núñez J, et al. [Post-reperfusion lymphopenia and microvascular obstruction in ST-segment elevation acute myocardial infarction]. Rev Esp Cardiol 2009; 62:1109-17. Spanish. http://dx.doi.org/10.1016/S0300-8932(09)72379-6 | ||||
27. Dormandy J, Ernst E, Matrai A, Flute PT. Hemorrheologic changes following acute myocardial infarction. Am Heart J 1982; 104:1364-7. http://dx.doi.org/10.1016/0002-8703(82)90169-7 | ||||
28. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol 1988; 11:1309-16. http://dx.doi.org/10.1016/0735-1097(88)90297-5 | ||||
29. Schmid-Schönbein GW. The damaging potential of leucocyte activation in the microcirculation. Angiology 1993; 44:45-56. http://dx.doi.org/10.1177/000331979304400108 | ||||
30. Engler RL, Schmid-Schönbein GW, Pavelec RS. Leucocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983; 111:98-111. |